NRC
NRC Health
20.30$
-0.4%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 25.9% | 30.8% | 34.1% | 19.4% | 26.3% | 17.3% | 19.8% | -3.3% | 39.8% | 20.4% | 20.6% | 3.9% | 21.1% | |
| 4.1% | 3.8% | 4.1% | 4.3% | 4.3% | 4.1% | 4.6% | 5.1% | 6.3% | 6.1% | 6.2% | 6.0% | 6.2% | |
| 0.2% | 0.7% | -0.1% | -0.2% | 0.5% | 0.5% | 0.5% | 0.9% | 2.7% | 5.4% | 4.6% | 20.8% | 8.4% | |
| 0.7% | 3.7% | 12.4% | -2.8% | 5.2% | -4.0% | -8.7% | -4.0% | 18.9% | -3.9% | 0.7% | -13.9% | 0.4% | |
| 11.8% | 9.9% | 11.7% | 15.0% | 4.5% | 12.0% | 8.9% | 8.8% | 10.4% | 3.2% | 5.3% | 3.7% | 5.6% | |
| -11.8% | -9.9% | -11.7% | -15.0% | -17.9% | -12.0% | -8.9% | -8.8% | -10.4% | -3.2% | -5.3% | -3.7% | -5.6% | |
| 72.5% | 7.8% | 8.2% | 8.2% | 8.0% | 7.6% | 8.3% | 8.0% | 8.0% | 7.7% | 10.4% | 10.2% | 9.1% | |
| -0.8% | -39.5% | -42.5% | 0.0% | -23.9% | -20.0% | -14.7% | -17.6% | -26.8% | 0.0% | -5.6% | -21.6% | -13.5% | |
| – | – | – | – | 31.9% | 24.5% | 7.5% | 46.2% | -2.7% | -2.9% | -3.0% | 33.8% | 6.4% | |
| -63.3% | -13.5% | -36.4% | -7.8% | 0.0% | -3.2% | -16.1% | 20.3% | -38.2% | -11.8% | -19.9% | 2.0% | -16.8% | |
| -49.2% | 7.4% | -14.0% | -3.5% | 8.3% | 2.1% | -5.2% | 8.1% | -8.8% | 5.5% | -4.6% | 2.2% | -1.4% | |
| 14.1% | 20.9% | 22.4% | 4.3% | 21.8% | 5.2% | 10.9% | -12.2% | 29.4% | 17.2% | 15.4% | 0.2% | 15.5% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.